On 22nd of September 2020 the company "Ananta Medicare" in association with "Clinic of modern rheumatology" held the first webinar on the topic of osteoporosis. The lecture "Osteoporosis - from idea to action" was conducted by prof. Egudina Elizaveta Davydovna.
Scenic Biotech founders and biologists have designed their own functional genomics platform to accurately identify genes that modify a specific disease.
The steroidogenesis inhibitor levoketoconazole has improved laboratory parameters in adult patients with endogenous Cushing's disease.
The World Health Organization expects to receive 2 billion doses of COVID-19 vaccines under the COVAX program in 2021.
Experts believe that GALAPAGOS and GILEAD have managed to make a breakthrough on an experimental autotoxin inhibitor in the field of scleroderma therapy.
Clinical studies on VIR-2218 have shown an effective result in the fight against hepatitis B.
The FDA has assigned an orphan drug status to a drug based on rhenium nanoliposom.
A new class of drugs such as HIF-2α inhibitors is considered as an addition to standard cancer immunotherapy.
Chinese scientists are actively engaged in the development of improved immunomodulators.
Studies have shown that, on average, people eat about 5 grams of plastic every week.